Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1971 1
1976 1
1978 1
1981 1
1982 1
1983 1
1984 1
1990 1
1993 2
1994 1
1995 1
1997 2
1998 1
1999 2
2000 1
2002 1
2003 1
2004 2
2005 2
2006 2
2007 1
2008 1
2009 2
2010 3
2011 1
2012 9
2013 11
2014 5
2015 4
2016 4
2017 9
2018 14
2019 11
2020 15
2021 10
2022 15
2023 18
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for tingling sun
Search for Pingling Sun instead (1 results)
Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.
Drilon A, Camidge DR, Lin JJ, Kim SW, Solomon BJ, Dziadziuszko R, Besse B, Goto K, de Langen AJ, Wolf J, Lee KH, Popat S, Springfeld C, Nagasaka M, Felip E, Yang N, Velcheti V, Lu S, Kao S, Dooms C, Krebs MG, Yao W, Beg MS, Hu X, Moro-Sibilot D, Cheema P, Stopatschinskaja S, Mehta M, Trone D, Graber A, Sims G, Yuan Y, Cho BC; TRIDENT-1 Investigators. Drilon A, et al. N Engl J Med. 2024 Jan 11;390(2):118-131. doi: 10.1056/NEJMoa2302299. N Engl J Med. 2024. PMID: 38197815 Clinical Trial.
A total of 426 patients received the phase 2 dose; the most common treatment-related adverse events were dizziness (in 58% of the patients), dysgeusia (in 50%), and paresthesia (in 30%), and 3% discontinued repotrectinib owing to treatment-related adverse events. ...
A total of 426 patients received the phase 2 dose; the most common treatment-related adverse events were dizziness (in 58% of the patients), …
X-Linked Protoporphyria.
Balwani M, Desnick R; Porphyrias Consortium of the NIH-Sponsored Rare Diseases Clinical Research Network. Balwani M, et al. 2013 Feb 14 [updated 2019 Nov 27]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2013 Feb 14 [updated 2019 Nov 27]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 23409301 Free Books & Documents. Review.
CLINICAL CHARACTERISTICS: X-linked protoporphyria (XLP) is characterized in affected males by cutaneous photosensitivity (usually beginning in infancy or childhood) that results in tingling, burning, pain, and itching within minutes of sun/light exposure and may be …
CLINICAL CHARACTERISTICS: X-linked protoporphyria (XLP) is characterized in affected males by cutaneous photosensitivity (usually beginning …
Case 271.
Sun Y, Overby PJ, Mehta H. Sun Y, et al. Radiology. 2019 Jul;292(1):259-262. doi: 10.1148/radiol.2019170925. Radiology. 2019. PMID: 31219757
History An 11-year-old boy taking oral antibiotics for Fusobacterium meningitis diagnosed 3 months earlier presented to the emergency department with a 1-week history of intermittent emesis, dizziness, and vertigo and a 1-day history of wobbly gait and bilateral lower extremity …
History An 11-year-old boy taking oral antibiotics for Fusobacterium meningitis diagnosed 3 months earlier presented to the emergency depart …
Aquagenic cutaneous disorders.
Wang F, Zhao YK, Luo ZY, Gao Q, Wu W, Sarkar R, Luo DQ. Wang F, et al. J Dtsch Dermatol Ges. 2017 Jun;15(6):602-608. doi: 10.1111/ddg.13234. Epub 2017 May 17. J Dtsch Dermatol Ges. 2017. PMID: 28513988 Review.
Aquagenic pruritus presents with severe pruritus or a stinging, tingling, or burning sensation without any visible skin changes. These symptoms occur immediately or within minutes after the skin is exposed to water, lasting for one hour or longer. ...
Aquagenic pruritus presents with severe pruritus or a stinging, tingling, or burning sensation without any visible skin changes. Thes …
Erythropoietic Protoporphyria, Autosomal Recessive.
Balwani M, Bloomer J, Desnick R; Porphyrias Consortium of the NIH-Sponsored Rare Diseases Clinical Research Network. Balwani M, et al. 2012 Sep 27 [updated 2017 Sep 7]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2012 Sep 27 [updated 2017 Sep 7]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 23016163 Free Books & Documents. Review.
CLINICAL CHARACTERISTICS: Erythropoietic protoporphyria (EPP) is characterized by cutaneous photosensitivity (usually beginning in infancy or childhood) that results in tingling, burning, pain, and itching within 30 minutes after exposure to sun or ultraviolet light …
CLINICAL CHARACTERISTICS: Erythropoietic protoporphyria (EPP) is characterized by cutaneous photosensitivity (usually beginning in infancy o …
Peripheral Opioids.
Bigliardi PL, Bigliardi-Qi M. Bigliardi PL, et al. In: Carstens E, Akiyama T, editors. Itch: Mechanisms and Treatment. Boca Raton (FL): CRC Press/Taylor & Francis; 2014. Chapter 18. In: Carstens E, Akiyama T, editors. Itch: Mechanisms and Treatment. Boca Raton (FL): CRC Press/Taylor & Francis; 2014. Chapter 18. PMID: 24830018 Free Books & Documents. Review.
There are many different manifestations of itch or other related sensations, such as tingling, crawling, or irritation. Some of these more diffuse sensations are initiated in the central nervous system (CNS), but most originate from the periphery, in particular, the skin. …
There are many different manifestations of itch or other related sensations, such as tingling, crawling, or irritation. Some of these …
Sun pain and solar dysesthesia: A new challenge in clinical practice.
Calzavara-Pinton P, Tonon F, Calzavara-Pinton I. Calzavara-Pinton P, et al. Photodermatol Photoimmunol Photomed. 2024 Mar;40(2):e12955. doi: 10.1111/phpp.12955. Photodermatol Photoimmunol Photomed. 2024. PMID: 38361492 Review.
As a result, these patients carefully avoid even short-term sun exposure with a consequent severe negative impact on their lives. ...Six of these patients were previously described by our group with the diagnosis of sun pain. We have reviewed the similarities with o …
As a result, these patients carefully avoid even short-term sun exposure with a consequent severe negative impact on their lives. ... …
Case 271: Metronidazole-induced Encephalopathy.
Sun Y, Overby PJ, Mehta H. Sun Y, et al. Radiology. 2019 Nov;293(2):473-479. doi: 10.1148/radiol.2019171079. Radiology. 2019. PMID: 31622182
HistoryAn 11-year-old boy taking oral antibiotics for Fusobacterium meningitis diagnosed 3 months earlier presented to the emergency department with a 1-week history of intermittent emesis, dizziness, and vertigo and a 1-day history of wobbly gait and bilateral lower extremity …
HistoryAn 11-year-old boy taking oral antibiotics for Fusobacterium meningitis diagnosed 3 months earlier presented to the emergency departm …
Safety of capecitabine: a review.
Mikhail SE, Sun JF, Marshall JL. Mikhail SE, et al. Expert Opin Drug Saf. 2010 Sep;9(5):831-41. doi: 10.1517/14740338.2010.511610. Expert Opin Drug Saf. 2010. PMID: 20722491 Review.
Clinical, neurophysiological and serological clues for the diagnosis of neuromyotonia and distinction from cramp-fasciculation syndrome.
Spagni G, Modoni A, Primiano G, Luigetti M, Sun B, Falso S, Monte G, Distefano M, Granata G, Evoli A, Damato V, Iorio R. Spagni G, et al. Neuromuscul Disord. 2023 Aug;33(8):636-642. doi: 10.1016/j.nmd.2023.06.010. Epub 2023 Jun 28. Neuromuscul Disord. 2023. PMID: 37422355
Neural antibodies were detected in 10/10 neuromyotonia sera, most commonly against contactin-associated protein 2 (7/10, 70%), and in 1/20 (5%) cramp-fasciculation syndrome sera. Clinical myokymia, hyperhidrosis, and paresthesia or neuropathic pain were more common in neur …
Neural antibodies were detected in 10/10 neuromyotonia sera, most commonly against contactin-associated protein 2 (7/10, 70%), and in 1/20 ( …
148 results